Applying computational protein design to therapeutic antibody discovery -- current state and perspectives

Abstract

'Dawid Chomicz' 'Sonia Wrobel' 'Victor Greiff' 'Ryan Feehan' 'Jared Adolf-Bryfogle' 'Konrad Krawczyk'] Abstract: Machine learning applications in protein sciences have ushered in a new era for designing molecules in silico. Antibodies, which currently form the largest group of biologics in clinical use, stand to benefit greatly from this shift. Despite the proliferation of these protein design tools, their direct application to antibodies is often limited by the unique structural biology of these molecules. Here, we review the current computational methods for antibody design, highlighting their role in advancing computational drug discovery.